W. Skovrider-Ruminski

Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal.

E. Høgdall, P. Geertsen, D. Linnemann, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prevalence of EBV and CMV DNA in epithelial ovarian cancer

E. Høgdall, C. Høgdall, J. Blaakaer, 2019, Infectious Agents and Cancer.

Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour – A Methodological Assessment Study

A. Krarup-Hansen, E. Høgdall, L. Penninga, 2022, AntiCancer Research.

High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population

E. Høgdall, C. Høgdall, L. Nedergaard, 2016, Infectious Agents and Cancer.

Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance.

F. Fraggetta, E. Høgdall, G. Improta, 2016, Oncology letters.

Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics

D. Nielsen, E. Høgdall, B. Jensen, 2018, Cancer Chemotherapy and Pharmacology.

The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis

E. Høgdall, C. Høgdall, J. Blaakaer, 2017, Infectious Agents and Cancer.

Frequency and coexistence of KRAS, NRAS, BRAF and PIK3CA mutations and occurrence of MMR deficiency in Danish colorectal cancer patients

E. Høgdall, L. Klarskov, T. Poulsen, 2020, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

The prevalence of EBV and CMV DNA in epithelial ovarian cancer

E. Høgdall, C. Høgdall, J. Blaakaer, 2019, Infectious agents and cancer.